106 related articles for article (PubMed ID: 2099398)
21. Sustained cytogenetic response after discontinuation of imatinib mesylate in a patient with chronic myeloid leukaemia.
Ghanima W; Kahrs J; Dahl TG; Tjonnfjord GE
Eur J Haematol; 2004 Jun; 72(6):441-3. PubMed ID: 15128424
[TBL] [Abstract][Full Text] [Related]
22. No significance of derivative chromosome 9 deletion on the clearance kinetics of BCR/ABL fusion transcripts, cytogenetic or molecular response, loss of response, or treatment failure to imatinib mesylate therapy for chronic myeloid leukemia.
Kim DH; Popradi G; Sriharsha L; Kamel-Reid S; Chang H; Messner HA; Lipton JH
Cancer; 2008 Aug; 113(4):772-81. PubMed ID: 18543309
[TBL] [Abstract][Full Text] [Related]
23. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
Ohnishi K; Minami S; Ueda T; Nishimura M; Tsubaki K; Takemoto Y; Takeshita A; Sao H; Kageyama S; Ueda R; Ohno R
Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674
[TBL] [Abstract][Full Text] [Related]
24. CML clonal evolution with resistance to single agent imatinib therapy.
Swords R; Quinn J; Fay M; O'Donnell R; Goldman J; Murphy PT
Clin Lab Haematol; 2005 Oct; 27(5):347-9. PubMed ID: 16178920
[TBL] [Abstract][Full Text] [Related]
25. Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation: durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host disease.
DeAngelo DJ; Hochberg EP; Alyea EP; Longtine J; Lee S; Galinsky I; Parekkedon B; Ritz J; Antin JH; Stone RM; Soiffer RJ
Clin Cancer Res; 2004 Aug; 10(15):5065-71. PubMed ID: 15297408
[TBL] [Abstract][Full Text] [Related]
26. [Chronic myelogenous leukemia following therapy for pineal germinoma].
Noda M; Shoda T; Takimoto Y; Okita H
Rinsho Ketsueki; 2004 Jan; 45(1):72-4. PubMed ID: 14999938
[TBL] [Abstract][Full Text] [Related]
27. [Interferon-alpha in the treatment of patients with chronic myeloid leukemia].
Faber E; Jarosová M; Divoký V; Luhový M; Komenda S; Sulovská I; Hubácek J; Slezák P; Papajik T; Raida L; Heczko M; Indrák K
Vnitr Lek; 1997 Jan; 43(1):13-7. PubMed ID: 9221559
[TBL] [Abstract][Full Text] [Related]
28. Complete cytogenetic and molecular responses to interferon-alpha-based therapy for chronic myelogenous leukemia are associated with excellent long-term prognosis.
Kantarjian HM; O'Brien S; Cortes JE; Shan J; Giles FJ; Rios MB; Faderl SH; Wierda WG; Ferrajoli A; Verstovsek S; Keating MJ; Freireich EJ; Talpaz M
Cancer; 2003 Feb; 97(4):1033-41. PubMed ID: 12569603
[TBL] [Abstract][Full Text] [Related]
29. Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease.
Posthuma EF; Marijt EW; Barge RM; van Soest RA; Baas IO; Starrenburg CW; van Zelderen-Bhola SL; Fibbe WE; Smit WM; Willemze R; Falkenburg JH
Biol Blood Marrow Transplant; 2004 Mar; 10(3):204-12. PubMed ID: 14993886
[TBL] [Abstract][Full Text] [Related]
30. [The assessment of therapeutic success in chronic myeloid leukemia].
Griesshammer M; Hehlmann R; Heimpel H
Dtsch Med Wochenschr; 1995 Apr; 120(17):620-5. PubMed ID: 7537652
[No Abstract] [Full Text] [Related]
31. Interferon-alpha plus low-dose cytosine arabinoside in advanced phase chronic myelogenous leukaemia patients.
Ferrajoli A; Liberati AM; Caricchi P; Donti E; Morra E; Lazzarino M; Betti AR; Bernasconi P; Saglio G
Eur J Haematol; 1995 Sep; 55(3):184-8. PubMed ID: 7672091
[TBL] [Abstract][Full Text] [Related]
32. [A case of chronic myeloid leukemia with cytogenetic remission and disappearance of Ph1 positive cells due to interferon-alpha administration].
Yoshida M; Fujiwara Y; Yoshinaga H; Maeda T; Mori Y; Nonaka K; Senoo K; Atsui F
Nihon Naika Gakkai Zasshi; 1991 May; 80(5):766-7. PubMed ID: 1875114
[No Abstract] [Full Text] [Related]
33. Breakpoint localization within the M-bcr and clinical course do not correlate in patients with chronic myelogenous leukemia undergoing alfa interferon therapy.
Opalka B; Wandl U; Beer U; Roggenbuck U; Kloke O; Niederle N
Leukemia; 1991 Jun; 5(6):452-6. PubMed ID: 2056769
[TBL] [Abstract][Full Text] [Related]
34. Interferon alpha induced and maintained complete remission in chronic granulocytic leukemia in relapse after bone marrow transplantation.
Borgies P; Ferrant A; Delannoy A; Van den Berghe H; Michaux JL
Bone Marrow Transplant; 1989 Jan; 4(1):127-8. PubMed ID: 2647178
[TBL] [Abstract][Full Text] [Related]
35. Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-alpha therapy. The Leukemia Service.
Kantarjian HM; Smith TL; O'Brien S; Beran M; Pierce S; Talpaz M
Ann Intern Med; 1995 Feb; 122(4):254-61. PubMed ID: 7825760
[TBL] [Abstract][Full Text] [Related]
36. Predicting complete cytogenetic response in chronic myelogenous leukemia patients treated with recombinant interferon alpha.
Mahon FX; Montastruc M; Faberes C; Reiffers J
Blood; 1994 Nov; 84(10):3592-4. PubMed ID: 7832859
[No Abstract] [Full Text] [Related]
37. Long-term follow-up results of alpha interferon therapy in chronic myelogenous leukemia at M. D. Anderson Cancer Center.
Kantarjian HM; Talpaz M
Leuk Lymphoma; 1993; 11 Suppl 1():169-74. PubMed ID: 8251891
[No Abstract] [Full Text] [Related]
38. [Recent progress in the treatment of hematological malignancies. IV. Chronic myelocytic leukemia].
Nagi K; Kamada N
Nihon Naika Gakkai Zasshi; 1989 Jun; 78(6):792-5. PubMed ID: 2794660
[No Abstract] [Full Text] [Related]
39. [Therapy of chronic myeloid leukemia with interferon].
Fülle HH; Dahmen E; Hellriegel KP
Onkologie; 1988 Aug; 11(4):177-83. PubMed ID: 3054669
[TBL] [Abstract][Full Text] [Related]
40. The combination of hydroxyurea and leucapheresis in the treatment of chronic myeloid leukaemia in pregnancy.
Fitzgerald JM; McCann SR
Clin Lab Haematol; 1993; 15(1):63-5. PubMed ID: 8472499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
